Vanguard Group’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84M Buy
1,074,253
+3,936
+0.4% +$308K ﹤0.01% 1899
2025
Q1
$77.4M Sell
1,070,317
-13,880
-1% -$1M ﹤0.01% 1902
2024
Q4
$96.2M Buy
1,084,197
+6,393
+0.6% +$567K ﹤0.01% 1891
2024
Q3
$91.2M Buy
1,077,804
+8,006
+0.7% +$678K ﹤0.01% 1915
2024
Q2
$98.9M Sell
1,069,798
-2,804
-0.3% -$259K ﹤0.01% 1843
2024
Q1
$121M Buy
1,072,602
+10,175
+1% +$1.15M ﹤0.01% 1766
2023
Q4
$99M Buy
1,062,427
+26,224
+3% +$2.44M ﹤0.01% 1870
2023
Q3
$95.1M Buy
1,036,203
+17,156
+2% +$1.57M ﹤0.01% 1829
2023
Q2
$124M Buy
1,019,047
+97,149
+11% +$11.8M ﹤0.01% 1736
2023
Q1
$90.3M Sell
921,898
-678
-0.1% -$66.4K ﹤0.01% 1875
2022
Q4
$74.8M Sell
922,576
-15,857
-2% -$1.28M ﹤0.01% 1962
2022
Q3
$71.3M Buy
938,433
+1,380
+0.1% +$105K ﹤0.01% 1996
2022
Q2
$102M Buy
937,053
+9,573
+1% +$1.05M ﹤0.01% 1814
2022
Q1
$92.2M Buy
927,480
+10,015
+1% +$996K ﹤0.01% 1991
2021
Q4
$87.7M Buy
917,465
+11,819
+1% +$1.13M ﹤0.01% 2060
2021
Q3
$100M Sell
905,646
-10,666
-1% -$1.18M ﹤0.01% 1978
2021
Q2
$106M Buy
916,312
+2,680
+0.3% +$311K ﹤0.01% 1968
2021
Q1
$95.1M Buy
913,632
+22,630
+3% +$2.36M ﹤0.01% 1973
2020
Q4
$107M Buy
891,002
+28,691
+3% +$3.45M ﹤0.01% 1794
2020
Q3
$74.9M Sell
862,311
-31,844
-4% -$2.77M ﹤0.01% 1823
2020
Q2
$72.4M Sell
894,155
-16,755
-2% -$1.36M ﹤0.01% 1821
2020
Q1
$62.9M Buy
910,910
+16,222
+2% +$1.12M ﹤0.01% 1757
2019
Q4
$102M Sell
894,688
-14,234
-2% -$1.63M ﹤0.01% 1742
2019
Q3
$119M Buy
908,922
+27,340
+3% +$3.57M ﹤0.01% 1635
2019
Q2
$108M Buy
881,582
+37,926
+4% +$4.65M ﹤0.01% 1712
2019
Q1
$88.6M Buy
843,656
+19,613
+2% +$2.06M ﹤0.01% 1811
2018
Q4
$84.3M Buy
824,043
+56,642
+7% +$5.8M ﹤0.01% 1776
2018
Q3
$91M Buy
767,401
+43,050
+6% +$5.11M ﹤0.01% 1851
2018
Q2
$69.5M Buy
724,351
+11,235
+2% +$1.08M ﹤0.01% 1950
2018
Q1
$58M Buy
713,116
+8,997
+1% +$731K ﹤0.01% 1997
2017
Q4
$50.8M Buy
704,119
+12,923
+2% +$933K ﹤0.01% 2051
2017
Q3
$42.5M Buy
691,196
+35,672
+5% +$2.19M ﹤0.01% 2117
2017
Q2
$39.6M Buy
655,524
+13,991
+2% +$845K ﹤0.01% 2128
2017
Q1
$41.9M Buy
641,533
+39,290
+7% +$2.57M ﹤0.01% 2094
2016
Q4
$42.3M Buy
602,243
+3,957
+0.7% +$278K ﹤0.01% 2061
2016
Q3
$37.5M Buy
598,286
+20,904
+4% +$1.31M ﹤0.01% 2067
2016
Q2
$34.8M Buy
577,382
+18,585
+3% +$1.12M ﹤0.01% 2062
2016
Q1
$27.8M Buy
558,797
+18,231
+3% +$907K ﹤0.01% 2148
2015
Q4
$29M Buy
540,566
+86,518
+19% +$4.64M ﹤0.01% 2140
2015
Q3
$20.4M Buy
454,048
+16,143
+4% +$725K ﹤0.01% 2285
2015
Q2
$24M Buy
437,905
+7,612
+2% +$417K ﹤0.01% 2276
2015
Q1
$20.4M Buy
430,293
+20,197
+5% +$959K ﹤0.01% 2313
2014
Q4
$17.2M Buy
410,096
+2,773
+0.7% +$116K ﹤0.01% 2297
2014
Q3
$14.4M Sell
407,323
-337
-0.1% -$11.9K ﹤0.01% 2332
2014
Q2
$13.9M Buy
407,660
+5,597
+1% +$191K ﹤0.01% 2366
2014
Q1
$13.9M Buy
402,063
+12,825
+3% +$443K ﹤0.01% 2335
2013
Q4
$13.7M Buy
389,238
+9,661
+3% +$341K ﹤0.01% 2322
2013
Q3
$11.8M Buy
379,577
+5,000
+1% +$155K ﹤0.01% 2327
2013
Q2
$10.4M Buy
+374,577
New +$10.4M ﹤0.01% 2318